Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald T Moir

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hitBing Li, Ramdas Pai, Daniel Aiello, et al.
Journal of Medicinal Chemistry|February 17, 2010
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitorsBing Li, Ramdas Pai, Steven C Cardinale, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2009
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formationTimothy J Opperman, Steven M Kwasny, John D Williams, et al.
Bioorganic & Medicinal Chemistry|March 2, 2010
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepRTimothy J Opperman, John D Williams, Chad Houseweart, et al.
Bioorganic & Medicinal Chemistry|May 30, 2009
Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicasesDaniel Aiello, Marjorie H Barnes, Esther E Biswas, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2010
Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretionDaniel Aiello, John D Williams, Helena Majgier-Baranowska, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2010
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolatesMichelle M Butler, John D Williams, Norton P Peet, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa InfectionBryan J Berube, Katherine R Murphy, Matthew C Torhan, et al.
Applied and Environmental Microbiology|July 23, 2013
Characterization of the Burkholderia thailandensis SOS response by using whole-transcriptome shotgun sequencingRicky L Ulrich, David Deshazer, Tara A Kenny, et al.
Journal of Medicinal Chemistry|December 13, 2012
Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activitiesBing Li, Ramdas Pai, Ming Di, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hitBing Li, Ramdas Pai, Daniel Aiello, et al.
Journal of Medicinal Chemistry|February 17, 2010
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitorsBing Li, Ramdas Pai, Steven C Cardinale, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2009
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formationTimothy J Opperman, Steven M Kwasny, John D Williams, et al.
Bioorganic & Medicinal Chemistry|March 2, 2010
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepRTimothy J Opperman, John D Williams, Chad Houseweart, et al.
Bioorganic & Medicinal Chemistry|May 30, 2009
Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicasesDaniel Aiello, Marjorie H Barnes, Esther E Biswas, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2010
Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretionDaniel Aiello, John D Williams, Helena Majgier-Baranowska, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2010
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolatesMichelle M Butler, John D Williams, Norton P Peet, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2017
Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa InfectionBryan J Berube, Katherine R Murphy, Matthew C Torhan, et al.
Applied and Environmental Microbiology|July 23, 2013
Characterization of the Burkholderia thailandensis SOS response by using whole-transcriptome shotgun sequencingRicky L Ulrich, David Deshazer, Tara A Kenny, et al.
Journal of Medicinal Chemistry|December 13, 2012
Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activitiesBing Li, Ramdas Pai, Ming Di, et al.
Pageof 4